mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.9 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.9 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |